DR. REDDYS LAB Fact Sheet, DR. REDDYS LAB Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB Fact Sheet    (REDY)


Alert: Discover the Makings of Potential 'Crorepati' Stocks from Richa Agarwal


Here is the latest financial fact sheet of DR. REDDYS LAB. For more details, see the DR. REDDYS LAB quarterly results and DR. REDDYS LAB share price and chart. For a sector overview, read our pharmaceuticals sector report.

DR. REDDYS LAB Price History

Price Rs 4,688.2
Mkt Cap Rs m 780,196
Vol '000 5.8
P/E X 41.3
P/CF X 24.9
EPS (TTM) Rs 113.4
1 Day % -0.8
No. of shares m 166.42
1 Week % -1.1
1 Month % 2.0
1 Year % -11.4
52 week H/L Rs 5,613.7/4,135.9
As on Jan 14, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DR. REDDYS LAB Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
DR. REDDYS LAB EQUITY SHARE DATA
High Rs3,3972,7882,8753,3635,515 
Low Rs2,5601,9021,8882,3523,028 
Sales per share (Unadj.) Rs856.5860.8930.21,054.21,145.4 
Earnings per share (Unadj.) Rs75.955.0114.8118.5114.5 
Diluted earnings per shareRs75.554.8114.5118.4114.4 
Cash flow per share (Unadj.) Rs137.8119.9183.1188.5188.4 
Dividends per share (Unadj.) Rs20.0020.0020.0025.0025.00 
Adj. dividends per shareRs19.9219.9419.9624.9624.98 
Avg Dividend yield %0.70.90.80.90.6 
Book value per share (Unadj.) Rs735.0752.8839.7932.51,053.2 
Adj. book value per shareRs732.0750.5837.9931.11,052.5 
Shares outstanding (eoy) m165.74165.91166.07166.17166.30 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x3.52.72.62.73.7 
Avg P/E ratio x39.342.620.724.137.3 
P/CF ratio (eoy) x21.619.613.015.222.7 
Price / Book Value ratio x4.13.12.83.14.1 
Dividend payout %26.436.417.421.121.8 
Avg Mkt Cap Rs m493,637389,036395,486474,837710,289 
No. of employees `000NANANANANA 
Total wages/salary Rs m31,06832,14933,56233,80236,299 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
DR. REDDYS LAB INCOME DATA
Net Sales Rs m141,961142,810154,482175,170190,475 
Other income Rs m1,7151,5523,3756,2062,914 
Total revenues Rs m143,676144,362157,857181,376193,389 
Gross profit Rs m24,72223,51231,78224,70438,699 
Depreciation Rs m10,26610,77211,34811,63112,288 
Interest Rs m634788889983970 
Profit before tax Rs m15,53713,50422,92018,29628,355 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2,9654,3803,858-1,4039,319 
Profit after tax Rs m12,5729,12419,06219,69919,036 
Gross profit margin %17.416.520.614.120.3 
Effective tax rate %19.132.416.8-7.732.9 
Net profit margin %8.96.412.311.210.0 
DR. REDDYS LAB BALANCE SHEET DATA
Current assets Rs m96,837104,984111,101125,991145,503 
Current liabilities Rs m84,19968,93858,97372,14181,038 
Net working cap to sales %8.925.233.730.733.8 
Current ratio x1.21.51.91.71.8 
Inventory Days Days6874727161 
Debtors Days Days981049410595 
Net fixed assets Rs m114,544115,054109,23894,063109,979 
Share capital Rs m829830830831832 
"Free" reserves Rs m120,988124,060138,611154,119174,319 
Net worth Rs m121,817124,890139,441154,950175,151 
Long term debt Rs m5,44925,08922,0001,3046,299 
Total assets Rs m211,381220,038220,339220,054255,482 
Interest coverage x25.518.126.819.630.2 
Debt to equity ratio x00.20.200 
Sales to assets ratio x0.70.60.70.80.7 
Return on assets %6.24.59.19.47.8 
Return on equity %10.37.313.712.710.9 
Return on capital %12.79.514.712.316.2 
Exports to sales %54.650.957.448.151.3 
Imports to sales %7.913.212.422.618.1 
Exports (fob) Rs m77,52072,62388,67384,19397,699 
Imports (cif) Rs m11,26818,91619,10439,61634,420 
Fx inflow Rs m81,67072,62388,67384,19397,699 
Fx outflow Rs m26,35518,91619,10439,61634,420 
Net fx Rs m55,31553,70769,56944,57763,279 
DR. REDDYS LAB CASH FLOW
From Operations Rs m 21,444 18,030 28,704 29,841 35,703 
From Investments Rs m -18,404 -14,883 -7,727 -4,923 -22,660 
From Financial Activity Rs m -3,692 -4,440 -21,326 -25,159 -298 
Net Cashflow Rs m -1,143 -1,236 -314 -266 12,858 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 26.7%
Institution 49.2%
Non-Institution 24.1%
Total 100.0%
Free Float 73.3%
Pledged promoter holdings 0.0%
Shareholding as on Sep 2021
 

Company Information

Regd Off 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500034
E-mail sureshvs@drreddys.com ; shares@drreddys.com Web www.drreddys.com
Tel 040 - 4900 2900 Fax 040 - 4900 2999
Sector PHARMACEUTICALS Group Dr. Reddy's Group
Tr Agent Bigshare Services Pvt Ltd, 306 Right Wing Amrutha Ville Opp. Yasodha Hospital, Raj Bhavan Road, Somajiguda
Auditor B. S. R & Co.
CHM: G. V. Prasad COMP SEC: Sandeep Poddar YEAR OF INC: 1984 BSE CODE: 500124 FV (Rs): 5 DIV YIELD (%): 0.5

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    CADILA HEALTHCARE    

Compare DR. REDDYS LAB With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    CADILA HEALTHCARE    




Today's Market

Indian Indices End Flat Amid Volatility; Asian Paints, Axis Bank & HUL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Views on news

Dr Reddy's New Covid-19 Treatment Option Puts Stock in Focus (Views On News)

May 24, 2021

With the second wave pushing up sales of medicines, Indian pharma companies are likely to see traction in their volumes.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

India's Best Semiconductor Stocks Views On News (Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You (Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

My Best Sectors for 2022 (Fast Profits Daily)

Jan 4, 2022

My top 2 sectors for 2022 might surprise you.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB - AARTI DRUGS COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS